Somatic RUNX1 aberrations are recurrently detected in various myeloid malignancies, such as myelodysplastic syndrome (MDS), acute myeloid leukemia (AML) [16], and myeloproliferative neoplasms. This evidence concerns the gene RUNX1 and myeloproliferative disorder.